NEW CASE STUDY Unlocking the power of process analytical technology to boost downstream operations    Dive in today!
Contact Us
Contact Us

Nick McDonald

AGC Biologics FDA Commercial Approval Copenhagen

2 min read

AGC Biologics Strengthens Portfolio with Latest FDA Commercial Approval at Company’s Copenhagen Facility

August 27, 2024 at 11:05 AM
Mammalian & mAbs Press Release Business Updates
Read press release
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines

2 min read

NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines

August 7, 2024 at 7:02 PM
Press Release Business Updates Microbial
Read press release
AGC Biologics' Seattle Headquarters

1 min read

AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications

July 29, 2024 at 6:30 AM
Mammalian & mAbs Press Release Business Updates
Read press release

2 min read

Essential Pharma and AGC Biologics Partner on late-phase clinical manufacturing of immunotherapy candidate for the treatment of high-risk neuroblastoma

June 17, 2024 at 12:00 AM
Mammalian & mAbs Press Release Business Updates
Read press release
Ben Clauberg appointed VP of Business Development EU

1 min read

AGC Biologics Appointments Ben Clauberg as Vice President, Business Development of European Market

June 14, 2024 at 7:26 AM
Press Release Business Updates
Read press release

1 min read

AGC Biologics & CEO Patricio Massera Announce Plans for Him to Step Down

June 12, 2024 at 12:05 AM
Press Release Business Updates
Read press release
AGC Biologics Copenhagen officially opens their new facility expansion.

2 min read

AGC Biologics Completes Copenhagen Campus Expansion, Doubling Single-use Mammalian Bioreactor Capacity at Site

June 4, 2024 at 12:00 AM
Mammalian & mAbs Press Release Business Updates
Read press release
AGC Biologics is partnering with BioConnection to simplify the path to DP for biologics projects.

2 min read

AGC Biologics and BioConnection Partner to Offer New End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering

May 22, 2024 at 3:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
Illustration of new AGC Biologics Yokohama Site

1 min read

AGC Biologics selects Cytiva to provide FlexFactory platforms in new biomanufacturing facility in Japan

April 25, 2024 at 5:53 AM
Mammalian & mAbs Press Release Business Updates mRNA Content
Read press release
AGC Biologics and VAR2 Pharmaceuticals Completion of antibody late stage clinical work

1 min read

AGC Biologics Announces Successful Completion of Production of Cancer-Specific Therapeutic Antibody Fragments with Var2 Pharmaceuticals

April 23, 2024 at 8:00 PM
Mammalian & mAbs Press Release Business Updates
Read press release
1 2 3 4 5 Next